WellAve Dermatology is thrilled to announce that Dr. Allan Harrington, a renowned Mohs Surgeon with over 35 years of dermatology experience, has officially joined the WellAve Dermatology team as Chief ...
Researchers conducted a post hoc analysis to evaluate incidence, severity, and time to first onset of rash and paronychia in patients with lung cancer treated with amivantamab. Rash, paronychia, and ...
BOULDER, CO / ACCESSWIRE / October 22, 2024 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...
BOULDER, CO / ACCESSWIRE / October 21, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized ...